Stay updated on mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial.
Sign up to get notified when there's something new on the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page.

Latest updates to the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added. The government funding operating-status notice and the Revision: v3.4.1 entry were removed.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide operating status notice and a revision update were added, and a few study-related topics/keywords were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedGlossary display and related topic links (Melanoma, MedlinePlus Genetics) were added. Revision and update-related metadata were updated (e.g., Last Update..., No FEAR Act Data, Revision: v3.4.0) and some older update fields were removed.SummaryDifference0.4%

- Check42 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing Revision: v3.3.3.SummaryDifference0.0%

- Check64 days agoChange DetectedThe study Locations were updated to include additional US and Australian sites and to remove certain previously listed sites.SummaryDifference2%

- Check71 days agoChange DetectedRemoval of related topics entries for Melanoma and MedlinePlus Genetics from the study page, removing supplementary navigational items. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page.